EurekAlert! -
14 Mar 2016 06:00
(Goethe University Frankfurt) Emmanuelle Charpentier and Jennifer A. Doudna have developed the bacterial gene cutter CRISPR-Cas9 in such a way that specific DNA sequences can be targeted and cleaved. The technology is opening up completely new perspectives for research.
Share this Article